DiscoverThe Parexel PodcastDe-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept
De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept

De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept

Update: 2024-07-16
Share

Description

De-risking Drug Development is a five-part podcast series that explores the business-critical decisions that take place at each stage of the drug development process. We know that novel therapies often don’t meet their revenue expectations, but through informed decision-making, you can minimize risk and maximize the probability of commercial success.


This is episode three, where we discuss how to accelerate development and opportunities to differentiate your product through innovative and adaptive trial design. We focus on the importance of creating evidence packages that meet both regulatory and payer requirements, and the critical role of early value story development alongside target product profile (TPP) planning.

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept

De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept

PAREXEL